ArticleEpilepsy & behavior reports2025

Early antiseizure response to cenobamate (200 mg/day) in focal drug-resistant epilepsy: a retrospective single-center analysis.

Ewa Czapińska-Ciepiela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.